Related Experiment Video
Updated: Jan 15, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Glucose-lowering effects of physical activity in type 1 diabetes: A causal modelling and matched-pair analysis
John S Pemberton1, Catherine L Russon2, Richard M Pulsford2
1Birmingham Women's and Children's Hospitals NHS Foundation Trust, Diabetes Centre, Birmingham, UK.
Aims:
To evaluate the acute glucose-lowering effect of bouts of physical activity (PA) for hyperglycaemia in individuals with type 1 diabetes, using a within-subject matched-pairs causal design to approximate the control condition of no activity.
Methods:
Data comprised 1546 PA bouts of 10-30 min from 482 participants in the T1DEXI and T1DEXIP cohorts where glucose was >10 mmol/L. Each PA bout was matched [starting glucose, glucose rate of change, insulin on board (IOB) and glucose variability (CV)] to a matched non-PA period within the same individual using a weighted k-nearest neighbours algorithm (SMD <0.01).
Primary Outcome:
Change in glucose from PA onset to 20 min post-activity.
Secondary Outcomes:
Predictors of glucose response and rate of hypoglycaemia incidence.
Results:
PA [median 23 min: IQR (20, 30)] led to a mean glucose change of -2.2 mmol/L (p < 0.001), compared with 0.3 mmol/L (p < 0.001) during matched non-PA periods (mean difference: -1.9 mmol/L (p < 0.0001)). No significant differences by age, activity type or intensity were observed. The strongest predictors of PA-induced glucose change were (in order) glucose rate of change, starting glucose, CV, duration and IOB. A heatmap using starting glucose and glucose rate of change was developed to guide real-time decision-making. PA-induced hypoglycaemia risk was very low (<2%).
Conclusion/Interpretation:
Using PA to lower high glucose levels is an effective and safe strategy, and when guided by CGM, it can become a personalised tool for type 1 diabetes education.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Dipeptidyl Peptidase 4 Inhibitors

